Friday · October 9, 2026
Emerging

Gut Bacteria May Cause Childhood Asthma by Reprogramming Immune Cells

Researchers combined genetic causal inference with stool sequencing from asthmatic children and found that specific gut bacteria appear to shift childhood asthma risk by reprogramming immune cells, not just correlating with it.

Gut Bacteria May Cause Childhood Asthma by Reprogramming Immune Cells

If you suspect your child's asthma has something to do with their gut, a new study gives that hunch real scientific backing, and a plausible mechanism to go with it.

Researchers in China combined a genetic causal-inference method with direct stool sequencing from asthmatic children to trace how specific gut bacteria might drive childhood asthma, not just accompany it. The study, published in The Clinical Respiratory Journal, identified two immune cell types that appear to physically carry the signal from the gut to the immune system, offering one of the more detailed pictures yet of how the gut-lung axis (the two-way communication network between gut bacteria and lung immune function) might work in children.

Key takeaways:

  • Using genetic data from over 314,000 people, researchers found seven gut bacteria types with a statistically significant causal link to childhood asthma risk, three that raise it and four that appear protective.
  • Two specific immune cell markers, CD64 on one type of monocyte and CD45 on a type of T cell, seem to carry part of that signal from gut bacteria to asthma risk.
  • Stool sequencing from a small group of asthmatic and healthy children lined up with the genetic findings, but the clinical sample was small and the genetic data came entirely from European populations, so this is early evidence, not a finished mechanism.

Gut Microbiota Traits Show Causal Link to Childhood Asthma

Researchers found that seven specific gut bacteria taxa (types) have a statistically significant causal relationship with childhood asthma, using a genetic method called Mendelian randomization (MR), which uses inherited genetic variants as natural experiments to test cause and effect without the confounding that plagues typical observational studies. Three bacteria types were linked to higher asthma risk: Bacteroides thetaiotaomicron (odds ratio, or OR, of 1.874), Ruminococcus torques (OR 1.617), and the family Clostridiales (OR 1.002). Four others appeared protective, most notably Lachnospiraceae (OR 0.461) and Paraprevotella (OR 0.616). The team also ran the analysis in reverse and found no evidence that asthma itself was reshaping the gut microbiome, supporting the idea that the bacteria are influencing risk rather than the other way around.

Why This Matters for Families Managing Childhood Asthma

Asthma remains one of the most common chronic conditions of childhood, and researchers estimate it affects roughly 334 million people worldwide across all ages, with prevalence continuing to climb in many countries. Between an estimated 10% and 30% of children experience early wheezing episodes, and as many as a quarter have recurrent wheezing before they start school. For parents who already suspect diet, gut health, or early antibiotic exposure played a role in their child's asthma, this study is among the more rigorous attempts yet to test that suspicion with genetic causal methods rather than just correlation, and to explain a biological pathway that could make sense of it.

How Researchers Tested the Gut-Immune-Asthma Link

The study layered three lines of evidence. First, the team ran a two-sample MR analysis using gut microbiota genetic data from the MiBioGen consortium, drawn from over 18,000 people across 24 cohorts, and childhood asthma genetic data from the UK Biobank, covering 314,633 participants (13,962 diagnosed with childhood-onset asthma before age 19, and 300,671 without). Second, they tested 731 immune cell traits from a separate genetic dataset for their own causal links to asthma, and identified 25 immune cell types with significant associations. Third, mediation analysis was used to check whether gut bacteria influence asthma risk through those immune cells rather than by a separate, unrelated path.

The genetic work was then checked against real biology: the researchers recruited 33 children at Tongji Hospital in Wuhan, China, 25 with diagnosed childhood asthma and 8 age-matched healthy controls, and ran metagenomic sequencing (whole-genome sequencing of the bacteria in a stool sample, rather than sequencing just one marker gene) on their fecal samples. This is a small clinical validation cohort, but its purpose was narrower than the genetic analysis, to check whether the bacterial patterns predicted by MR actually show up in real children's guts.

Two Immune Cell Types Appear to Carry the Signal

The mediation analysis pointed to two specific pathways. Paraprevotella bacteria were associated with higher levels of CD64 on a subset of monocytes (a type of white blood cell involved in innate immune defense), and that immune shift accounted for about 16.2% of Paraprevotella's protective effect against asthma. Separately, Bacteroides thetaiotaomicron was associated with lower levels of CD45 on a type of T cell marked by HLA-DR, and that shift accounted for roughly 7.35% of its asthma-risk-raising effect. In plain terms, these bacteria are not just present alongside asthma, they appear to be nudging specific immune cells in ways that then move asthma risk up or down.

The stool sequencing backed this up from a different angle. Children with asthma had guts enriched in Bacteroides, the same genus flagged as risk-raising in the genetic analysis, while healthy children had more Akkermansia and Lachnospiraceae, both generally considered beneficial gut residents. The asthmatic children's samples also showed higher levels of bacterial virulence factors linked to species like Klebsiella pneumoniae and Pseudomonas aeruginosa, and differences in microbial genes tied to glucose metabolism and immune regulation, though the researchers stress these functional findings are preliminary and haven't been confirmed with direct metabolite measurements.

What This Does, and Doesn't, Mean for Your Child

Nothing here supports giving a child a specific probiotic, restricting a specific food, or otherwise intervening based on this study alone, and the researchers do not claim otherwise. What it does offer is a more credible biological story, that certain gut bacteria may shift childhood asthma risk by altering how specific immune cells behave, which is a more actionable target for future research and eventual treatment development than a loose correlation. If your child has asthma and you're curious whether gut health is a contributing factor, this study is a reasonable thing to mention to their pediatrician or pulmonologist as context, not a basis for self-directed treatment. No approved gut-microbiota-targeted therapy for childhood asthma exists yet.

What the Study Doesn't Answer Yet

The authors are upfront about the limits. The genetic data underlying the MR analysis came entirely from people of European ancestry, which limits how confidently the findings generalize to other populations. The clinical validation cohort was small, just 25 asthmatic children and 8 controls, spanned a wide age range, and did not control for factors known to affect both the gut microbiome and asthma risk, including body weight, diet, pet exposure, secondhand smoke, and geography. The researchers also note that the immune cell GWAS instruments were built from adult populations and applied to a pediatric outcome, an assumption that may not hold perfectly across development. No metabolite-level or animal-model experiments confirmed the specific biological steps proposed here, so the mechanism remains a well-supported hypothesis rather than a proven pathway.

What Comes Next

The researchers frame this as a foundation for further work, not a final answer. They call for larger, better-matched case-control cohorts to confirm the clinical findings, longitudinal studies that track children's gut microbiomes over time to separate cause from correlation as they age, and animal-model experiments to directly test whether manipulating Paraprevotella or Bacteroides thetaiotaomicron levels changes asthma outcomes. No timeline for that follow-up work was given.

Common Questions

Does this mean probiotics can prevent or treat childhood asthma? No. The study identifies a possible causal pathway between certain gut bacteria and asthma risk, but it did not test any probiotic, diet, or supplement, and the researchers make no such recommendation.

Which gut bacteria were linked to higher asthma risk? Bacteroides thetaiotaomicron, Ruminococcus torques, and the bacterial family Clostridiales were each linked to increased childhood asthma risk in the genetic analysis, while Lachnospiraceae and Paraprevotella were linked to lower risk.

How is this different from earlier studies linking gut bacteria to asthma? Most earlier work found associations between gut bacteria and asthma without establishing cause and effect. This study used Mendelian randomization, a genetic method that helps rule out reverse causation and confounding, and paired it with direct stool sequencing from asthmatic children to check the genetic predictions against real biological samples.

Does this apply to adult asthma too? This study specifically modeled childhood-onset asthma, diagnosed before age 19, and the clinical validation cohort was children only. The findings should not be assumed to apply to adult-onset asthma without separate research.

Evidence Rating

EMERGING — 78/100

Caveats

  • MR relies on adult-population GWAS instruments applied to a pediatric outcome
  • modest clinical metagenomic validation cohort (25 asthma cases, 8 controls)

Dual-method study combining Mendelian randomization (MR) and metagenomic sequencing traces a causal path from specific gut microbiota traits to childhood asthma via immune-cell mediation.

References

Rui Shi, Zongming Yang, Xiuyun Zhou, et al. (2026). Immune Cell–Mediated Causal Link Between Gut Microbiota Traits and Childhood Asthma: Evidence From Mendelian Randomization and Metagenomic Sequencing. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70227